Lanosterol
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Lanosterol
Description:
Lanosterol is an intermediate of cholesterol synthesis and use of lanosterol induces ubiquitination and degradation of a rate-controlling enzyme of cholesterol synthesis, i.e., HMG CoA reductase. Lanosterol suppresses the aggregation and cytotoxicity of misfolded proteins linked with neurodegenerative diseases[1][2].UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
Endogenous MetaboliteType:
Natural ProductsRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
Metabolism-sugar/lipid metabolismField of Research:
Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/Lanosterol.htmlPurity:
99.97Solubility:
Ethanol : 10 mg/mL (ultrasonic)Smiles:
C[C@]12C3=C(CC[C@@]1([C@]([C@H](C)CC/C=C(C)/C)([H])CC2)C)[C@@]4([C@@](C(C)([C@@H](O)CC4)C)([H])CC3)CMolecular Formula:
C30H50OMolecular Weight:
426.72Precautions:
H302, H315, H319, H335References & Citations:
[1]Upadhyay A, et al. Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases. Mol Neurobiol. 2018;55 (2) :1169-1182.|[2]Lee S, et al. Lanosterol influences cytoplasmic maturation of pig oocytes in vitro and improves preimplantation development of cloned embryos. Theriogenology. 2016;85 (4) :575-584.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
Human Endogenous MetaboliteCAS Number:
[79-63-0]
